Cutler Group LLC / CA - BROOKLYN IMMUNOTHERAPEUTICS ownership

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$21,000
+600.0%
3,947
+97.4%
0.00%
Q4 2021$3,000
-92.1%
2,000
-92.8%
0.00%
-100.0%
Q3 2021$38,000
-56.3%
27,700
+60.1%
0.00%
-66.7%
Q2 2021$87,00017,3000.00%
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
Cypress Point Wealth Management, LLC 471,878$8,499,0006.04%
BALDWIN BROTHERS LLC/MA 44,116$795,0000.09%
DOWLING & YAHNKE LLC 15,806$285,0000.02%
INVERNESS COUNSEL LLC /NY/ 13,307$240,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 15,000$270,0000.01%
Cutler Group LLC / CA 4,200$75,0000.00%
MetLife Investment Management, LLC 10,805$194,5980.00%
HAP Trading, LLC 13,900$64,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 8,272$148,9790.00%
Ameritas Investment Partners, Inc. 1,867$34,0000.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders